The novel therapy of the medication represents a significant advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – leading to https://tirzepatide-peptide483087.blogspothub.com/40718374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment